EA202191266A1 - ANTI-CANCER THERAPY BASED ON IMMUNOCYTE BINDING PTK7 - Google Patents

ANTI-CANCER THERAPY BASED ON IMMUNOCYTE BINDING PTK7

Info

Publication number
EA202191266A1
EA202191266A1 EA202191266A EA202191266A EA202191266A1 EA 202191266 A1 EA202191266 A1 EA 202191266A1 EA 202191266 A EA202191266 A EA 202191266A EA 202191266 A EA202191266 A EA 202191266A EA 202191266 A1 EA202191266 A1 EA 202191266A1
Authority
EA
Eurasian Patent Office
Prior art keywords
immunocyte
cancer therapy
therapy based
ptk7
binding
Prior art date
Application number
EA202191266A
Other languages
Russian (ru)
Inventor
Джонатан Александр Терретт
Джейсон Сэйджерт
Original Assignee
Криспр Терапьютикс Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Криспр Терапьютикс Аг filed Critical Криспр Терапьютикс Аг
Priority claimed from PCT/IB2019/059585 external-priority patent/WO2020095248A1/en
Publication of EA202191266A1 publication Critical patent/EA202191266A1/en

Links

Abstract

В данном документе, в некоторых вариантах осуществления, предусмотрены способы и композиции (например, композиции на основе клеток) для лечения рака, такого как PTK7+ злокачественные новообразования.Provided herein, in some embodiments, are methods and compositions (eg, cell-based compositions) for treating cancer, such as PTK7 + cancers.

EA202191266A 2019-10-04 2019-11-07 ANTI-CANCER THERAPY BASED ON IMMUNOCYTE BINDING PTK7 EA202191266A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962910586P 2019-10-04 2019-10-04
PCT/IB2019/059585 WO2020095248A1 (en) 2018-11-07 2019-11-07 Anti-ptk7 immune cell cancer therapy

Publications (1)

Publication Number Publication Date
EA202191266A1 true EA202191266A1 (en) 2021-08-10

Family

ID=77515186

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191266A EA202191266A1 (en) 2019-10-04 2019-11-07 ANTI-CANCER THERAPY BASED ON IMMUNOCYTE BINDING PTK7

Country Status (1)

Country Link
EA (1) EA202191266A1 (en)

Similar Documents

Publication Publication Date Title
PH12020551923A1 (en) Methods and compositions for treating cancer
EA202191257A1 (en) ANTI-CANCER THERAPY BASED ON IMMUNOCYTES BINDING LIV1
PH12021550152A1 (en) Anti-cd112r compositions and methods
MX2021005398A (en) Anti-cd33 immune cell cancer therapy.
MX2019001517A (en) Modified antibody-albumin nanoparticle complexes for cancer treatment.
WO2021007428A3 (en) Molecules, compositions and methods for treatment of cancer
AU2018265888A1 (en) Use of anti-B7H3 antibodies for treating cancer in the central nervous system
MX2020012091A (en) Anti-cd24 compositions and uses thereof.
EA202091887A1 (en) COMBINED CANCER THERAPY USING MULTI-SPECIFIC BINDING PROTEINS THAT ACTIVATE NATURAL KILLER CELLS
JOP20210314A1 (en) Tigit and pd-1/tigit-binding molecules
MX2022005411A (en) Il-2rî²î³c binding compounds.
ZA201907225B (en) Treatment of her2 positive cancers
BR112021015477A2 (en) Anti-cd228 antibodies and antibody-drug conjugates
CL2021001260A1 (en) Humanized anti-sirpa antibodies
MX2021005400A (en) Anti-ptk7 immune cell cancer therapy.
MX2022000726A (en) Immunomodulatory antibodies and methods of use thereof.
BR112019024719A2 (en) COMPOSITIONS AND METHODS FOR IMPROVED ANTITUMOR IMMUNOLOGICAL RESPONSE
ZA202206993B (en) Anti-lilrb1 antibody and uses thereof
WO2022082073A3 (en) Compositions and methods for muc18 targeting
MX2021008834A (en) Methods of treating breast cancer with tucatinib.
EA201991305A1 (en) Tyrosine Derivatives and Compositions Including Theirs
EA201792286A1 (en) METHODS OF TREATING CANCER
BR112019007365A2 (en) methods and compositions for tusc2 immunotherapy
EA202191266A1 (en) ANTI-CANCER THERAPY BASED ON IMMUNOCYTE BINDING PTK7
MX2021003527A (en) Low-intensity treatment of hematological disorders.